Tris Pharma announced positive topline results from the ALLEVIATE-2 phase III clinical trial of investigational cebranopadol to treat moderate-to-severe acute pain after bunionectomy surgery. Axonal ...
Ocrelizumab significantly reduced the number and volume of cortical lesions associated with multiple sclerosis at 120 weeks, ...
For decades, scientists have focused on amyloid plaques—abnormal clumps of misfolded proteins that accumulate between neurons ...
ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company focused on the generation and development of ...
A Regina mother who was one of the first ALS patients to test a new treatment is now celebrating its accelerated approval in ...
Daily Express US on MSN4d
Motor neuron disease: Easy-to-dismiss symptom could be a sign of debilitating conditionMotor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback